Impact of Severity and Disease Course on Baricitinib Treatment Response in Adolescent Patients with Severe AA from the BRAVE-AA-PEDS Trial. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 May 2];9(6):s665. Available from: https://skin.dermsquared.com/skin/article/view/3853